Did our AI summary help? Scientists are testing an experimental approach that could potentially shift heart disease prevention away from lifelong medication and toward a single-dose genetic ...

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new study, ...

With the promise of targeted gene editing and CRISPR technologies comes increasing experimental complexity and design challenges. Success in gene editing experiments may depend on many variables, some ...

The landscape of gene editing applications is expanding quickly. More and more, researchers are faced with choosing the right tools and protocols for genome engineering, including overexpressing ...

Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and ...